MedAvail Holdings, Inc.
MDVLQOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$161
P/E Ratio—
52W High$0.0002
52W Low$0.0001
MedAvail Holdings, Inc. (MDVLQ) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MDVLQ · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2023Report Date: Jun 30, 2023EPS Actual
-$3.22
Revenue
$0.00B
Est. $0.00B · -46.8%
Fiscal Period
Q2 FY2023
FY ends December
Report Date
Jun 30, 2023
After Market Close
▼ Miss Revenue
MDVLQ reports quarterly as a OTC-listed Medical - Pharmaceuticals company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$93.32
Rev. $1001.5B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$93.32
Rev. Est.$1001.5B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 18, 2026 | -$1.00 | — | — | — | $0.01B | — |
| ◌ Q2 FY2026 | May 29, 2026 | -$2.00 | — | — | — | $0.01B | — |
| ◌ Q1 FY2026 | Feb 25, 2026 | -$0.50 | — | — | — | $0.01B | — |
| ◌ Q2 FY2024 | May 29, 2024 | — | — | — | — | $0.00B | — |
| — Q2 FY2023 | Jun 30, 2023 | — | -$3.22 | — | $0.00B | $0.00B | -46.8% |
| — Q1 FY2023 | Mar 31, 2023 | — | -$10.79 | — | $0.00B | — | — |
| — Q4 FY2022 | Dec 31, 2022 | — | -$6.91 | — | $0.01B | $0.01B | +3.2% |
| — Q3 FY2022 | Sep 30, 2022 | — | -$7.37 | — | $0.01B | $0.01B | +1.4% |
Q3 FY2026
Aug 18, 2026
EPS Actual
—
EPS Est.
-$1.00
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 29, 2026
EPS Actual
—
EPS Est.
-$2.00
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 25, 2026
EPS Actual
—
EPS Est.
-$0.50
EPS Surpr.
—
Revenue
—
Q2 FY2024
May 29, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2023
Jun 30, 2023
EPS Actual
-$3.22
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2023
Mar 31, 2023
EPS Actual
-$10.79
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2022
Dec 31, 2022
EPS Actual
-$6.91
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q3 FY2022
Sep 30, 2022
EPS Actual
-$7.37
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2026 | $-0.50 | $-0.50 | $-0.50 | 1 |
| Q2 FY2026 | $-1.00 | $-1.00 | $-1.00 | 1 |
| Q1 FY2026 | $-2.00 | $-2.00 | $-2.00 | 1 |
| Q4 FY2025 | $-0.50 | $-0.50 | $-0.50 | 1 |
| Q3 FY2025 | $-0.50 | $-0.50 | $-0.50 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2023 | Jun 30, 2023 | — | $12.00 | $12.26 | +2.17% |
| — Q1 FY2023 | Mar 31, 2023 | — | $15.23 | $14.33 | -5.91% |
| — Q4 FY2022 | Dec 31, 2022 | — | $14.99 | $14.60 | -2.60% |
| — Q3 FY2022 | Sep 30, 2022 | — | $39.85 | $38.80 | -2.63% |
| — Q2 FY2022 | Jun 30, 2022 | — | $78.00 | $76.50 | -1.92% |
| — Q1 FY2022 | Mar 31, 2022 | — | $50.00 | $48.56 | -2.88% |
| — Q4 FY2021 | Dec 31, 2021 | — | $68.00 | $70.00 | +2.94% |
| — Q3 FY2021 | Sep 30, 2021 | — | $144.00 | $146.00 | +1.39% |
Q2 FY2023+2.17%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$12.00
Price After
$12.26
Q1 FY2023-5.91%
Report Date
Mar 31, 2023
EPS Beat/Miss
—
Price Before
$15.23
Price After
$14.33
Q4 FY2022-2.60%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$14.99
Price After
$14.60
Q3 FY2022-2.63%
Report Date
Sep 30, 2022
EPS Beat/Miss
—
Price Before
$39.85
Price After
$38.80
Q2 FY2022-1.92%
Report Date
Jun 30, 2022
EPS Beat/Miss
—
Price Before
$78.00
Price After
$76.50
Q1 FY2022-2.88%
Report Date
Mar 31, 2022
EPS Beat/Miss
—
Price Before
$50.00
Price After
$48.56
Q4 FY2021+2.94%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$68.00
Price After
$70.00
Q3 FY2021+1.39%
Report Date
Sep 30, 2021
EPS Beat/Miss
—
Price Before
$144.00
Price After
$146.00
Beat Rate0 / 8 quarters
Largest Move-5.91% (Q1 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MDVLQ ends December
MedAvail Holdings, Inc. (MDVLQ) most recently reported earnings on June 30, 2023 for Q2 FY2023, posting EPS of $-3.22 (in line with the analyst consensus of —). The next MDVLQ earnings date is expected around September 1, 2026.
Each quarter, investors track MDVLQ earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MDVLQ revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MDVLQ's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MDVLQ earnings · 4 questionsMedAvail Holdings, Inc.'s next earnings report is expected around September 1, 2026. MDVLQ typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MDVLQ historically reports after market close (AMC).
MDVLQ earnings datewhen is MDVLQ earningsMDVLQ next earnings datewhen does MDVLQ report earningsMDVLQ earnings calendar
▸ Source: FMP · MedAvail Holdings, Inc. SEC filings · US GAAP · MedAvail Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026